Sponsor pipeline

CG Oncology, Inc. clinical trial pipeline

Get alerts when CG Oncology, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04452591 Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer… Non Muscle Invasive Bladder Cancer Active, Not Recruiting 2026-07-10
NCT06111235 A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk… Non Muscle Invasive Bladder Cancer Active, Not Recruiting 2026-07-01
Phase 2
NCT06567743 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in… High-Risk Non-Muscle-Invasive Bladder Cancer Recruiting 2026-09-03

Disease areas by active trials

Bladder Cancer (3)

Get alerts when CG Oncology, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free